You are here

Journal Club 6 January 2023

Articles for this journal club are shown below:

- Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers:  

- A Systematic Review and Recommendation for Reporting of Surrogate Endpoint Evaluation Using Meta-analyses:  

Presenter slide:  

Commentator slide:  



Department of Clinical Epidemiology and Biostatistics